pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 9·1 min read
save

NIH names John Powers III as acting director of NIAID amid leadership uncertainty

Jun 9, 2026·read at STAT ↗Neutral

The National Institutes of Health has appointed researcher John Powers III to serve as acting director of the National Institute of Allergy and Infectious Diseases (NIAID). Powers previously served as a senior adviser at NIAID and was the deputy to former director Jeffrey Taubenberger.

The appointment follows weeks of uncertainty after the previous director stepped down and the institute has been without a permanent leader since the removal of Jeanne Marrazzo last March.

NIAID, the NIH's second-largest agency with a $6.5 billion budget, faces heightened scrutiny as the United States deals with a hantavirus outbreak and an Ebola outbreak in Central Africa. Lawmakers have voiced concerns about the institute's infectious disease expertise.

NIH staff were informed of the change via an internal email on Tuesday, confirming Powers will lead the institute on an acting basis while a permanent director is sought.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: NIAID appoints new acting director after weekslong questions over leadership”

read at STAT ↗
508 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health2The National Institute of Allergy and Infectious Diseases2
topics
Infectious Disease5

related stories

  • 1d agoHelen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69STAT
  • Jul 28Six key issues we’re watching at Fauci’s hearingSTAT
  • Apr 28Fauci adviser David Morens indicted on charges of concealing emails, avoiding records requestsSTAT
  • 2h agoAs White House shifts focus toward AI and tech, U.S. science leaders defend role of the American universitySTAT
  • 5d agoSTAT+: Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease roleSTAT